Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
Industry is frustrated by the cost and excessive timeframes of obtaining real-world data for autonomous vehicle (AV) development. Using simulated environments – specifically mmWave radar simulation – can slash costs
This whitepaper describes the benefits of introducing advanced wireless capabilities into surgical and critical care settings, the technical approaches to achieve this, and the challenges that can arise. It concludes with our vision for some exemplar use cases.
The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space?
Digital transformation is a huge topic, sweeping across many aspects of our lives, from ecommerce to the digitalization of internal systems. When we partnered with news publisher CGT (Consumer Goods Technology) for its latest webinar, we were keen to focus on a specific part of this topic – digitally enabled products. It was energizing to be joined by a world-class panel of industry experts as we swapped insights into how CPG brands can rise to this challenge.
The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment.